Expand KTTA Menu
KTTA MENU

KTTA Latest Press Releases

-- January 13, 2026 --

Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines Globe Newswire 7:01 AM

-- December 2, 2025 --

Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock Globe Newswire 7:00 AM

-- November 28, 2025 --

Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock Globe Newswire 9:20 AM

-- November 25, 2025 --

Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS Globe Newswire 7:00 AM

-- November 24, 2025 --

Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), and Pharmacodynamic (PD) Data Globe Newswire 7:00 AM

-- November 21, 2025 --

Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients Globe Newswire 12:35 PM

-- November 20, 2025 --

Pasithea Therapeutics Announces Positive Phase 1 Data Including Partial Response, Demonstrating Monotherapy Clinical Activity and Favorable Safety Profile for PAS-004 in Advanced Cancer Study Globe Newswire 4:01 PM

-- November 4, 2025 --

Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients Globe Newswire 7:03 AM

-- September 16, 2025 --

Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients Globe Newswire 7:03 AM

-- September 8, 2025 --

Pasithea Therapeutics Announces Enrollment of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for its Ongoing Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients Globe Newswire 7:01 AM

-- August 29, 2025 --

Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 8:39 AM

-- August 28, 2025 --

Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 7:02 AM
Market Data Delayed 15 Minutes